Megan Sweet sits at her lab bench at Virginia Tech with tumor tissue so thin it appears translucent, mounted on a glass slide and ready for scrutiny under a high-powered microscope. The painstaking work of slicing, staining, and comparing—repeated day after day—has yielded a discovery that helps explain why some cancers are far more aggressive than others. Her research, conducted with cell biologist Daniela Cimini and graduate student Mat Bloomfield over five years, reveals a sobering truth: cells with four complete sets of chromosomes, called tetraploid cells, can recruit the body's own non-cancerous support cells to fuel tumor growth.
This finding matters because cancer cells often contain abnormal chromosome numbers—a hallmark of the disease. But understanding exactly how those abnormalities drive aggressive progression has long remained elusive. The Virginia Tech team set out to answer a fundamental question: why do some tumors grow faster and more dangerously than others? Their work, published in the Proceedings of the National Academy of Sciences and in Cancer Research in 2026, reveals an unexpected mechanism that challenges how researchers think about tumor biology.
The story begins with basic cell biology. Most healthy cells in your body are diploid, meaning they contain two copies of each chromosome—one from each parent. When cells divide normally, they replicate this balanced state. But occasionally a dividing cell makes a mistake, doubling its chromosomes without completing cell division. This creates a tetraploid cell with four complete chromosome sets. When this happens during human tumor development, it's associated with cancer progression and poor prognosis. Sweet and Bloomfield deliberately created tetraploid cancer cells in the lab to study what happened when tumors formed from them.
What they discovered was startling. When tetraploid cancer cells were transplanted into mice, the number of tetraploid cells actually decreased during tumor formation—yet the tumors grew rapidly and to a large size. In what Sweet describes as "a first-of-its-kind discovery," they found that even a small fraction of tetraploid cells drove the recruitment of stromal cells, the non-cancerous connective tissue cells that form structural support around tumors. In essence, the cancer cells were hijacking the body's own scaffolding system. "The presence of even a small fraction of these tetraploid cells can promote the recruitment of extra non-cancerous cells that support further tumor progression," Sweet said.
The research uncovered a second, equally striking pattern. When Bloomfield isolated individual clones of human tetraploid cancer cells, he noticed the clones differed in size—some were 25 to 30 percent smaller than expected for cells with four chromosome sets. The smaller clones proved far more dangerous. "The smaller clones are more aggressive," Bloomfield said. "They grow faster, are more invasive, and more tolerant of common anti-cancer and stress-inducing drugs." Experiments in mice confirmed that tumors containing smaller tetraploid cells grew more rapidly, regardless of cancer type.
These findings open new questions about how cancer cells evolve within tumors and which features predict the most dangerous variants. For patients and clinicians, the research suggests that cell size itself could become a marker for identifying aggressive cancers—a breakthrough that might one day help guide treatment decisions and improve outcomes.